​Microneedles for Keloids

Clinician Innovator: National Skin Centre
Industry Partner: Micropoint Pte Ltd

Problem Statement: Keloid management requires frequent triamcinolone injections, but conventional keloid injections are painful.
CMTi's involvement : CMTi connected NSC with Micropoint to develop microneedles as a painless alternative that could be self administrated, as well as help arrange for clinical trials for efficiacy
Product Status: Currently implemented at NSC for recommended patients

Click here to view other key projects